SEARCH

SEARCH BY CITATION

References

  • 1
    Böckle BC, Sepp N. Hepatitis C virus and autoimmunity. Autoimmun Highlights 2010; 1: 2335.
  • 2
    Marcos M, Alvarez F, Brito-Zeron P et al. Chronic hepatitis B virus infection in Sjogren’s syndrome. Prevalence and clinical significance in 603 patients. Autoimmun Rev 2009; 8: 61620.
  • 3
    Sousa GM, Oliveira RC, Pereira MM, Parana R, Sousa-Atta ML, Atta AM. Autoimmunity in hepatitis C virus carriers: involvement of ferritin and prolactin. Autoimmun Rev 2011; 10: 2103.
  • 4
    Sansonno L, Tucci FA, Sansonno S, Lauletta G, Troiani L, Sansonno D. B cells and HCV: an infection model of autoimmunity. Autoimmun Rev 2009; 9: 934.
  • 5
    Cacoub P, Delluc A, Saadoun D, Landau DA, Sene D. Anti-CD20 monoclonal antibody (rituximab) treatment for cryoglobulinemic vasculitis: where do we stand? Ann Rheum Dis 2008; 67: 2837.
  • 6
    Ramos-Casals M, Munoz S, Medina F et al. Systemic autoimmune diseases in patients with hepatitis C virus infection: characterization of 1020 cases (The HISPAMEC Registry). J Rheumatol 2009; 36: 14428.
  • 7
    Niewold TB, Swedler WI. Systemic lupus erythematosus arising during interferon-alpha therapy for cryoglobulinemic vasculitis associated with hepatitis C. Clin Rheumatol 2005; 24: 17881.
  • 8
    Zuckerman E, Slobodin G, Kessel A et al. Peripheral B-cell CD5 expansion and CD81 overexpression and their association with disease severity and autoimmune markers in chronic hepatitis C virus infection. Clin Exp Immunol 2002; 128: 3538.
  • 9
    Toubi E, Gordon S, Kessel A et al. Elevated serum B-Lymphocyte activating factor (BAFF) in chronic hepatitis C virus infection: association with autoimmunity. J Autoimmun 2006; 27: 1349.